S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0085 SEK Market Closed
Market Cap: 7.1m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

S2Medical AB (publ)
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Common Stock
kr16.9m
CAGR 3-Years
169%
CAGR 5-Years
91%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Common Stock
kr5.6m
CAGR 3-Years
59%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Common Stock
kr805k
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
D
Doxa AB
STO:DOXA
Common Stock
kr321.4m
CAGR 3-Years
84%
CAGR 5-Years
63%
CAGR 10-Years
51%
Bactiguard Holding AB
STO:BACTI B
Common Stock
kr876k
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Common Stock
€84k
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

S2Medical AB (publ)
Glance View

Market Cap
7.1m SEK
Industry
Health Care

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

S2M Intrinsic Value
0.0322 SEK
Undervaluation 74%
Intrinsic Value
Price
S

See Also

What is S2Medical AB (publ)'s Common Stock?
Common Stock
16.9m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Common Stock amounts to 16.9m SEK.

What is S2Medical AB (publ)'s Common Stock growth rate?
Common Stock CAGR 5Y
91%

Over the last year, the Common Stock growth was -29%. The average annual Common Stock growth rates for S2Medical AB (publ) have been 169% over the past three years , 91% over the past five years .

Back to Top